pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. million rare disease patients in the U.S. Caring for a global community.

Patients 79

Patients Pharma Consulting Transportation 79

World of DTC Marketing

JUNE 2, 2021

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Here are some basics: 1ne: Physicians receive a lot of emails and don’t have time to read every one. 100 percent of U.S.

Physicians 180

Physicians Doctors Marketing Sales 180

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. 5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. .

Pharma 98

Pharma Education Transportation Training 98

World of DTC Marketing

JANUARY 1, 2022

More and more patients demand a level of service they want with the increased costs of health insurance premiums. 1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections.

Healthcare 244

Healthcare Healthcare Side effects Prescription 244

pharmaphorum

SEPTEMBER 30, 2022

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. An oral version of edaravone was cleared this year.

FDA 86

FDA Doctors Patients Prescription 86

PM360

OCTOBER 13, 2023

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. and France regarding pharma-provided digital platforms. One participant summed up these perceptions by stating “It’s a pharmaceutical site, you know.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

World of DTC Marketing

SEPTEMBER 24, 2021

Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Biogen is in trouble.

Insurance 222

Insurance Pharma Doctors Physicians 222

World of DTC Marketing

JULY 5, 2022

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.

Insurance 200

Insurance Doctors Pharma Side effects 200

pharmaphorum

DECEMBER 12, 2022

The duo reduced the risk of disease progression or deaths by 40% compared to Faslodex plus placebo in patients whose cancer had progressed despite first-line hormone therapy, with or without a CDK 4/6 inhibitor. In a subgroup of patients with AKT-positive tumours – around half of all breast cancer patients – the reduction increased to 50%.

Pharma 91

Pharma Physicians Patients Leads 91

World of DTC Marketing

JULY 21, 2021

The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. They research the drug online and ask their physician about it if they decide it’s a treatment option. Again this is not true.

Marketing 285

Marketing Prescription Side effects Doctors 285

Pharma Leaders

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

PM360

APRIL 22, 2024

TAP INTO TRUST AND MAKE IT RELEVANT Many HCPs report approaching pharma-created content with suspicion of promotional agendas and bias. TAP INTO TRUST AND MAKE IT RELEVANT Many HCPs report approaching pharma-created content with suspicion of promotional agendas and bias. References: Physician Learning Preferences: A Doximity Report.

Physicians 52

Physicians Education Healthcare Healthcare 52

Pharma Marketing Network

JULY 10, 2023

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. Direct-to-physician (DTP) advertising: DTP advertising is advertising that is directed to healthcare providers.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40

Pharma Leaders

MARCH 27, 2023

Iovance Biotherapeutics has completed submission of the Biologics License Application (BLA) for lifileucel to the US Food and Drug Administration (FDA). Iovance has submitted BLA based on positive clinical data from the C-144-01 clinical study in patients with advanced post-anti-PD1 melanoma.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

European Pharmaceutical Review

MARCH 8, 2023

To mark International Women’s Day, EPR talked to Dr Ekaterina Malievskaia, Chief Innovation Officer and Co-founder of COMPASS Pathways about her inspiration, the challenges as a woman working in pharma and advice for women entering the industry. I am a physician by training, and I worked in New York hospital emergency rooms for many years.

Leads 52

Leads Pharma Food and Drug Administration Medicine 52

World of DTC Marketing

DECEMBER 23, 2020

DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. In an era of a pandemic, are psoriasis patients really going to ask for a drug that may compromise their immune system? What are other patients saying about it?

Prescription 249

Prescription Doctors Side effects Marketing 249

European Pharmaceutical Review

NOVEMBER 8, 2022

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. Citizen Petitions before the FDA. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

PM360

NOVEMBER 12, 2023

Here’s the fact: since the pandemic, launch revenues in pharma have declined. After a review of the professional literature and great advice from several colleagues in pharma, here are several things I would recommend. 1 That represents 200,000 fewer patients diagnosed or treated for their cancers.

Physicians 64

Physicians Marketing Sales Pharma 64

Pharma Marketing Network

APRIL 1, 2023

Pharma-Mkting.com is a leading resource for professionals in the pharmaceutical and medical device industries. With a focus on marketing and digital health, Pharma-Mkting.com provides a wealth of information, resources, and insights to help these industries succeed in an increasingly competitive market.

Pharma 52

Pharma Medical Pharmaceutical Marketing 52

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

PM360

AUGUST 9, 2022

2 and over a million actively licensed physicians 3 are available to prescribe them? Before you can drive scripts and maximize the impact of your pharma marketing budget, you have to account for three key trends that have impacted how drugs are prescribed. By 2020, that percentage plummeted to just 8%. References: 1.

Prescription 52

Prescription Doctors Specialization Physicians 52

Silver Line CRM

NOVEMBER 20, 2020

Reading time: 4 minutes Bringing new treatments to patients in dire need of additional options is why those of us who work in life sciences do what we do. A successful vaccine, treatment, or new medical device brings forth both new opportunities as well as challenges given a new group of patients with unique needs to be met.

Marketing 52

Marketing Pharma Side effects Training 52

pharmaphorum

SEPTEMBER 1, 2022

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. Dr. B was founded in 2021 to connect providers with leftover COVID vaccines to the patients seeking to receive them.

Medical 95

Medical Prescription Doctors Physicians 95

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

European Pharmaceutical Review

DECEMBER 1, 2023

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. So, because of the large molecule size, the difficulty was with absorption through the oral delivery system.

Food and Drug Administration 85

Food and Drug Administration Manufacturing Pharma Patients 85

World of DTC Marketing

FEBRUARY 2, 2021

When I first read these statistics, I thought, “what a great opportunity,” but I wanted to check with some physician thought leaders. ” She told me that she wanted to understand better how patients were using these apps, where the apps were developed, and if they had been studied to ensure they presented good clinical data.

Insurance 139

Insurance Doctors Healthcare Healthcare 139

MedReps

SEPTEMBER 19, 2022

There’s no shortage of challenges for those new to pharma, medical sales and even veterans. Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Physician Access. Physician Apathy. Insurance Coverage.

Medical sales 66

Medical sales Medical sales reps Medical Sales 66

Pharmaceutical Technology

MARCH 24, 2023

Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.

Competition 59

Competition Marketing FDA Physicians 59

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage. Connecting peers.

Media 84

Media Healthcare Healthcare Education 84

Clarivate

JULY 5, 2023

The month of July could see seven FDA-approved adalimumab biosimilars launch in the United States, an unprecedented situation for a market that has been relatively slow to embrace biosimilars. and European physicians across six specialties, and global pipeline analysis curated by experts to provide insights into the evolving landscape.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

AUGUST 9, 2022

Brand Beat: Juul Fights FDA Ban. Shortly after banning Juul from selling its products, the FDA placed a hold on its decision in order to review the company’s case more closely. however, the company is required to prove to the FDA that their e-cigarettes in fact benefit the public.

Healthcare 52

Healthcare Healthcare Food and Drug Administration FDA 52

Pharmaceutical Technology

SEPTEMBER 2, 2022

This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie. lenalidomide) + a steroid ± an anti-CD38 antibody. Does Blenrep have an efficacy advantage over Tecvayli?

Food and Drug Administration 59

Food and Drug Administration FDA Sales Physicians 59

PM360

SEPTEMBER 7, 2023

HCPs are depending on developers’ promised changes to make the platform more patient focused. Also, the platform holds promise as a more effective way for healthcare professionals to engage directly with patients. Despite these concerns, some HCPs are feeling positively about Threads. Ask me anything!” Tarsus Pharmaceuticals, Inc.

Healthcare 52

Healthcare Healthcare FDA Doctors 52

pharmaphorum

OCTOBER 13, 2022

In the last decade, there has also been rapid development and interest in CRISPR/Cas9 technology and other gene-editing tools that could offer transformative avenues to deliver gene therapies for patients and families affected by devastating diseases such as sickle cell disease and thalassemia. Bringing in the patient perspective.

Food and Drug Administration 52

Food and Drug Administration Side effects Patients FDA 52

Evolve Your Success

JUNE 28, 2022

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. Despite the very incredible data showing, endoscopic was better for the patient. We got a couple of our products FDA cleared and we raised our first venture financing. — Watch the episode here. Listen to the podcast here. Click To Tweet. Surgeons would pitch us.

Sales 52

Sales Pharma Medical sales reps Medical sales 52